Abhimanyu Garg, M.D. is a Professor of Internal Medicine in the Division of Endocrinology at UT Southwestern Medical Center in Dallas, Texas, where he also serves as Director of Metabolic Diseases in the Center for Human Nutrition, Director of the Nutrition and Metabolic Diseases Fellowship Program, and holder of the Distinguished Chair in Human Nutrition Research. His clinical practice is devoted to the evaluation and management of patients with lipodystrophy, lipid metabolism disorders, and related metabolic diseases. Abhimanyu Garg, M.D. earned his medical degree and completed his residency in internal medicine at the All India Institute of Medical Sciences. He subsequently completed fellowship training in endocrinology and metabolism at the University of Alabama at Birmingham and at UT Southwestern, where he joined the faculty in 1988. Abhimanyu Garg, M.D. is widely regarded as the leading global authority on lipodystrophy research and treatment, having devoted nearly three decades to advancing the understanding and management of these rare disorders. He was the first investigator to evaluate leptin as a therapeutic option for lipodystrophy through a clinical trial launched at UT Southwestern in 2000, work that directly contributed to the FDA's 2014 approval of metreleptin for the treatment of generalized lipodystrophy. His ongoing research focuses on whether leptin therapy can improve metabolic outcomes in hypoleptinemic patients with partial lipodystrophies. In addition to his clinical and research contributions, Abhimanyu Garg, M.D. is a recipient of the Jean D. Wilson, M.D. Award for excellence in scientific mentorship in the Division of Endocrinology and Metabolism at UT Southwestern. He holds membership in the American Diabetes Association, the Endocrine Society, the American Society of Human Genetics, and the Association of Specialty Professors, among other professional organizations.

Daniel A. Dumesic, MD is a Professor and Division Chief of Reproductive Endocrinology and Infertility in the Department of Obstetrics and Gynecology at the University of California, Los Angeles. He is affiliated with Ronald Reagan UCLA Medical Center and UCLA Medical Center-Santa Monica, where his clinical practice centers on female infertility, in vitro fertilization, and polycystic ovary syndrome. He serves as a member of the Practice Committee of the American Society for Reproductive Medicine and is a Fellow of the American College of Obstetricians and Gynecologists and a member of the Endocrine Society. Daniel A. Dumesic, MD earned his medical degree from the University of Wisconsin School of Medicine and Public Health and completed his residency in Obstetrics and Gynecology at the University of Minnesota. He went on to complete a fellowship in Reproductive Endocrinology and Infertility at the University of California, San Francisco. He is board-certified by the American Board of Obstetrics and Gynecology in both Obstetrics and Gynecology and Reproductive Endocrinology and Infertility. Daniel A. Dumesic, MD's research focuses on the mechanistic and clinical dimensions of female reproductive disorders, with particular emphasis on polycystic ovary syndrome and its metabolic consequences. His investigations have examined the role of androgen excess in adipogenic dysfunction in PMOS, the paracrine regulation of oocyte competence, and the interplay between body fat distribution, cortisol, and testosterone in affected women. He has served as Principal Investigator on multiple NIH-funded and university-awarded projects and has published over 200 papers in the field of reproductive endocrinology. His work spans both human clinical studies and translational research, and he has been an active contributor to NIH research study sections and committees throughout his career. In addition to his research, Daniel A. Dumesic, MD is widely recognized for his contributions to the field. He has received the Mayo Award for Excellence in Leadership and is a nine-time recipient of the American Society for Reproductive Medicine's Star Award, given for more than ten years of sustained contributions to research. Stanford University has ranked him within the top 2% of all scientists in clinical medicine globally. He has also been honored with the Ricardo Azziz Distinguished Researcher Award from the Androgen Excess and PMOS Society and has been named a Top Doctor in Southern California.

Susan L. Samson, M.D., Ph.D., FRCPC, FACE is a Professor of Medicine and Chair of the Division of Endocrinology, Diabetes, and Metabolism, with a cross appointment to the Department of Neurologic Surgery. She specializes in pituitary disorders and currently practices at Mayo Clinic. Susan L. Samson, M.D., Ph.D., FRCPC, FACE earned her medical degree in Canada, where she is a Fellow of the Royal College of Canada in Internal Medicine and Endocrinology. She completed her endocrinology training at Baylor College of Medicine and MD Anderson Cancer Center, where she subsequently served as Co-director of the Baylor St. Luke's Pituitary Center and Director of the Endocrinology Fellowship Program, training more than 60 fellows over the course of her tenure. Her clinical and research interests center on the diagnosis and management of pituitary disorders, including pituitary tumors, acromegaly, Cushing's syndrome and disease, prolactinomas, craniopharyngiomas, hypopituitarism, and pituitary cysts, inflammation, and infiltration. She has served as site principal investigator and international steering chair for clinical trials in acromegaly and Cushing's disease, and is a co-author on consensus documents for the diagnosis and management of acromegaly, growth hormone deficiency, and Cushing's syndrome. She also co-edited and co-authored the book Pituitary Disorders Throughout the Lifecycle, published by Springer Nature. In addition to her clinical and research contributions, Susan L. Samson, M.D., Ph.D., FRCPC, FACE has held numerous leadership roles in organized medicine. She served as the 2024 President of the American Association of Clinical Endocrinology and has contributed to AACE committees including as Chair of Endocrine University and the AACE Annual Meeting. She has also served on national bodies including the American Board of Internal Medicine, the Accreditation Council for Graduate Medical Education, and the American Program Directors of Endocrinology and Metabolism. During her time at Baylor College of Medicine, she was recognized with the Fulbright and Jaworski Faculty Excellence Award for Teaching and Evaluation, the Rising Star Award, and the Woman of Excellence Award.